These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16143579)

  • 21. Hemodynamic effects of a continuous infusion of levosimendan in critically ill patients with cardiogenic shock requiring catecholamines.
    Delle Karth G; Buberl A; Geppert A; Neunteufl T; Huelsmann M; Kopp C; Nikfardjam M; Berger R; Heinz G
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1251-6. PubMed ID: 14616323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utility of levosimendan, a new calcium sensitizing agent, in the treatment of cardiogenic shock due to myocardial stunning in patients with ST-elevation myocardial infarction: a series of cases.
    García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ
    J Clin Pharmacol; 2005 Jun; 45(6):704-8. PubMed ID: 15901754
    [No Abstract]   [Full Text] [Related]  

  • 23. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cardiogenic shock-- new therapeutic strategies].
    Andersen GØ; Eritsland J; Bjørnerheim R; Kløw NE; Jonassen A; Mangschau A
    Tidsskr Nor Laegeforen; 2005 May; 125(10):1318-21. PubMed ID: 15909001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levosimendan in the treatment of cardiogenic shock.
    Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
    Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan improves postresuscitation outcomes in a rat model of CPR.
    Huang L; Weil MH; Sun S; Cammarata G; Cao L; Tang W
    J Lab Clin Med; 2005 Nov; 146(5):256-61. PubMed ID: 16242524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty.
    Dominguez-Rodriguez A; Samimi-Fard S; Garcia-Gonzalez MJ; Abreu-Gonzalez P
    Int J Cardiol; 2008 Aug; 128(2):214-7. PubMed ID: 17643535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of levosimendan for treatment of cardiogenic shock associated with electrical storm.
    Grazi M; Lauri G; Carbucicchio C; Marenzi G
    Ann Intern Med; 2009 May; 150(10):738-40. PubMed ID: 19451590
    [No Abstract]   [Full Text] [Related]  

  • 29. Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction.
    Omerovic E; Råmunddal T; Albertsson P; Holmberg M; Hallgren P; Boren J; Grip L; Matejka G
    Vasc Health Risk Manag; 2010 Sep; 6():657-63. PubMed ID: 20859537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
    Omerovic E; Waagstein F; Swedberg K
    Eur J Heart Fail; 2010 Apr; 12(4):313-4. PubMed ID: 20335348
    [No Abstract]   [Full Text] [Related]  

  • 31. Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair.
    Ponschab M; Hochmair N; Ghazwinian N; Mueller T; Plöchl W
    Eur J Anaesthesiol; 2008 Aug; 25(8):627-33. PubMed ID: 18405408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of levosimendan in Takotsubo-related cardiogenic shock.
    Antonini M; Stazi GV; Cirasa MT; Garotto G; Frustaci A
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):119-20. PubMed ID: 19961441
    [No Abstract]   [Full Text] [Related]  

  • 33. Levosimendan in cardiogenic shock: the magic drug for every patient?
    Smetana P; Geppert A
    Crit Care Med; 2007 Dec; 35(12):2862-4. PubMed ID: 18043208
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of levosimendan for cardiogenic shock in a patient with the apical ballooning syndrome.
    De Santis V; Vitale D; Tritapepe L; Greco C; Pietropaoli P
    Ann Intern Med; 2008 Sep; 149(5):365-7. PubMed ID: 18765717
    [No Abstract]   [Full Text] [Related]  

  • 35. Levosimendan may improve weaning outcomes in venoarterial ECMO patients.
    Affronti A; di Bella I; Carino D; Ragni T
    ASAIO J; 2013; 59(6):554-7. PubMed ID: 24172260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison between dobutamine and levosimendan for management of postresuscitation myocardial dysfunction.
    Huang L; Weil MH; Tang W; Sun S; Wang J
    Crit Care Med; 2005 Mar; 33(3):487-91. PubMed ID: 15753736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Morelli A; De Castro S; Teboul JL; Singer M; Rocco M; Conti G; De Luca L; Di Angelantonio E; Orecchioni A; Pandian NG; Pietropaoli P
    Intensive Care Med; 2005 May; 31(5):638-44. PubMed ID: 15812624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early 'in-lab' use of levosimendan in patients with cardiogenic shock unsuitable for intra-aortic balloon pump counterpulsation.
    Summaria F; Mustilli M; Sette A; Lanzillo C; Romagnoli E
    Ther Adv Cardiovasc Dis; 2014 Feb; 8(1):28-31. PubMed ID: 24492986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Levosimendan reversing low output syndrome after heart transplantation.
    Petäjä LM; Sipponen JT; Hämmäinen PJ; Eriksson HI; Salmenperä MT; Suojaranta-Ylinen RT
    Ann Thorac Surg; 2006 Oct; 82(4):1529-31. PubMed ID: 16996977
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levosimendan: current status and future prospects.
    Archan S; Toller W
    Curr Opin Anaesthesiol; 2008 Feb; 21(1):78-84. PubMed ID: 18195615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.